1-3 of 3
Sanna Hulkki
Close
Sort by
Journal Articles

Single-Cell Genetic Analysis Reveals The Genetic Composition Of Founder Clones, Phylogenetic Patterns Of Branching and Parallel Evolution, and Clonal Fluctuations Following Patient Treatment In Multiple Myeloma

Lorenzo Melchor, PhD, Annamaria Brioli, MD, Christopher P Wardell, PhD, Alexander Murison, PhD, Nicola E Potter, PhD, Martin F Kaiser, MD, Rosemary A Fryer, PhD, David C Johnson, PhD, Dil Begum, BSc, Sanna Hulkki, Gowri Vijayaraghavan, Ian Titley, PhD, Michele Cavo, MD, Faith E Davies, MD, Brian A Walker, PhD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2013) 122 (21): 398.
https://doi.org/10.1182/blood.V122.21.398.398
Published: 2013
Journal Articles

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma

Brian A. Walker, Christopher P. Wardell, Lorenzo Melchor, Sanna Hulkki, Nicola E. Potter, David C. Johnson, Kerry Fenwick, Iwanka Kozarewa, David Gonzalez, Christopher J. Lord, Alan Ashworth, Faith E. Davies, Gareth J. Morgan
Journal: Blood
Blood (2012) 120 (5): 1077–1086.
https://doi.org/10.1182/blood-2012-03-412981
Published: 2012
Includes: Supplemental data
Journal Articles

Non-Cycling Cells From Acute Myeloid Leukemia Patients Harbor the FLT3-ITD Mutation and Are Insensitive to TKI258, a Potent FLT3-Directed Inhibitor, in Vitro .

Caroline L Alvares, Tino Schenk, Sanna Hulkki, Toon Min, Gowri Vijayaraghavan, Yeung Jenny, David Gonzalez, Eric So, Mel Greaves, Ian Titley, Kerol Bartolovic, Gareth Morgan
Journal: Blood
Blood (2009) 114 (22): 479.
https://doi.org/10.1182/blood.V114.22.479.479
Published: 2009